On July 22, 2025, MEI Pharma Inc. issued pre-funded warrants to purchase 6,022,869 shares of its Common Stock at $3.4199 per warrant to an investor in a private placement offering. On July 24, 2024, the investor exercised warrants to purchase 2,084,509 shares, paying an exercise price totaling $208.45.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-100341), on July 30, 2025, and is solely responsible for the information contained therein.
Comments